Nitrous Oxide for Pain Management of Intrauterine Device (IUD) Insertion

• Status: Completed
• Trial end date: 2014-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine whether Nitrous Oxide is effective in achieving pain control and satisfaction among nulliparous women getting the intrauterine device (IUD).

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of New Mexico
• Collaborator: Society of Family Planning
• Treatments: Cadexomer iodine; Chlorhexidine; Chlorhexidine gluconate; Iodine; Nitrous Oxide; Povidone; Povidone-Iodine

Criteria

Inclusion Criteria:

• Age >18 OR between the ages of 12-17 with a parent/legal guardian who can consent

• English speaking

• Desires a Mirena® or ParaGard® IUD

• Nulliparous woman

• Can use laughing gas

• Has not taken narcotic pain medications prior to procedure

Exclusion Criteria:

• Currently pregnant

• If you have been pregnant before, pregnancy lasting longer than 19 weeks, 6 days

• Less than 4 weeks have elapsed from the end of a spontaneous abortion or medical abortion.

• Desires Skyla® IUD

• Pelvic Inflammatory Disease in the last 3 months

• Current mucopurulent discharge

• Uterine anomaly that distorts the uterine cavity

• Known uterine fibroid with disruption of the uterine cavity

• Copper allergy/Wilson's disease (for ParaGard®)

• Current cervical or uterine cancer

• Inability to breathe through the nose

• Significant active upper airway infection